Cargando…

Impact of COVID-19 containment measures on patients with rheumatic and musculoskeletal disease in the UK and Europe: the REUMAVID study (phase1)

OBJECTIVES: The aim was to compare the impact of the first wave of the coronavirus disease 2019 (COVID-19) pandemic and lockdown measures on patients with rheumatic and musculoskeletal diseases (RMDs) in the UK and other European countries (OEC). METHODS: REUMAVID was an online cross-sectional surve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrison, Stephanie Rose, Garrido-Cumbrera, Marco, Navarro-Compán, Victoria, Correa-Fernández, José, Webb, Dale, Christen, Laura, Marzo-Ortega, Helena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690324/ https://www.ncbi.nlm.nih.gov/pubmed/34988357 http://dx.doi.org/10.1093/rap/rkab098

Ejemplares similares

Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1)
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Poor health and functioning in patients with axial spondyloarthritis during the COVID-19 pandemic and lockdown: REUMAVID study (phase 1)
por: Benavent, Diego, et al.
Publicado: (2022)

Impact of axial spondyloarthritis on mental health in Europe: results from the EMAS study
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Identifying parameters associated with delayed diagnosis in axial spondyloarthritis: data from the European map of axial spondyloarthritis
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Patients with Axial Spondyloarthritis are Great Consumers of Healthcare Resources, Especially Young and Women: Results from the Spanish Atlas
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2023)

Patient‐Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis Survey
por: Garrido‐Cumbrera, Marco, et al.
Publicado: (2021)

Implementation of a hybrid healthcare model in rheumatic musculoskeletal diseases: 6-months results of the multicenter Digireuma study
por: Benavent, D., et al.
Publicado: (2023)

Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS)
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2021)

Neurology of musculoskeletal and rheumatic disorders /
por: Nakano, Kenneth K.
Publicado: (1979)

Therapeutic drug monitoring of biopharmaceuticals in inflammatory rheumatic and musculoskeletal disease: a systematic literature review informing EULAR points to consider
por: Krieckaert, Charlotte, et al.
Publicado: (2022)

The impact of gender and sex on diagnosis, treatment outcomes and health-related quality of life in patients with axial spondyloarthritis
por: Marzo-Ortega, Helena, et al.
Publicado: (2022)

Advancing frontiers in rheumatic and musculoskeletal imaging
por: Albano, Domenico, et al.
Publicado: (2021)

COVID-19 in axial spondyloarthritis care provision: helping to straighten the long and winding road
por: Marzo-Ortega, Helena, et al.
Publicado: (2021)

Cannabidiol (CBD) in Rheumatic Diseases (Musculoskeletal Pain)
por: Boehnke, Kevin F., et al.
Publicado: (2022)

Priorities for rheumatic and musculoskeletal disease research in Ireland
por: Dorris, Emma R., et al.
Publicado: (2022)

The European Map of Axial Spondyloarthritis: Capturing the Patient Perspective—an Analysis of 2846 Patients Across 13 Countries
por: Garrido-Cumbrera, Marco, et al.
Publicado: (2019)

Key Challenges in Rheumatic and Musculoskeletal Disease Translational Research
por: Fearon, Ursula, et al.
Publicado: (2014)

The Valued Life Activities Scale (VLAs): linguistic validation, cultural adaptation and psychometric testing in people with rheumatic and musculoskeletal diseases in the UK
por: Prior, Y., et al.
Publicado: (2020)

Impact of COVID-19 pandemic social restriction measures on people with rheumatic and musculoskeletal diseases in the UK: a mixed-methods study
por: Smith, Toby O, et al.
Publicado: (2021)

Self-risk assessment for patients with rheumatic disease during the COVID-19 pandemic
por: Marzo-Ortega, Helena, et al.
Publicado: (2020)

Accelerometry-Based Activity Recognition and Assessment in Rheumatic and Musculoskeletal Diseases
por: Billiet, Lieven, et al.
Publicado: (2016)

The Third Eye of the Rheumatologist: Applications of Musculoskeletal Ultrasound in Rheumatic Diseases
por: Chen, Hsin-Hua
Publicado: (2017)

Evaluation of physical performance in musculoskeletal and rheumatic diseases with jumping mechanography
por: Dionyssiotis, Yannis, et al.
Publicado: (2019)

Implementation of podiatry telephone appointments for people with rheumatic and musculoskeletal diseases
por: Palmer, J. L., et al.
Publicado: (2021)

Editorial: Psychological impact and quality of life in rheumatic and musculoskeletal diseases
por: Talarico, Rosaria, et al.
Publicado: (2023)

Challenges of translating epidemiologic research: An application to rheumatic and musculoskeletal disorders
por: Lucas, Raquel
Publicado: (2021)

Ixekizumab improves sleep and work productivity in patients with non-radiographic axial spondyloarthritis: results from the COAST-X trial at 52 weeks
por: Deodhar, Atul, et al.
Publicado: (2021)

Counselling services embedded within rheumatology clinics could help bridge the gap in mental health care provision for adults with rheumatic diseases
por: Hayward, Georgia, et al.
Publicado: (2022)

Challenges of caring for homeless patients with rheumatic and musculoskeletal disorders in Los Angeles
por: Seto, Richard, et al.
Publicado: (2020)

Prevalence and pattern of comorbidities in chronic rheumatic and musculoskeletal diseases: the COMORD study
por: Ziade, Nelly, et al.
Publicado: (2020)

Editorial: Advance in B-cell therapies for the treatment of rheumatic and musculoskeletal diseases
por: Md Yusof, Md Yuzaiful, et al.
Publicado: (2022)

The urgent need to move upstream in caring for people with rheumatic and musculoskeletal diseases
por: Bouraoui, Aicha, et al.
Publicado: (2022)

Coping with rheumatic stressors (CORS) questionnaire: Spanish translation and cross-cultural adaptation
por: Benavent, Diego, et al.
Publicado: (2023)

Cost Containment in Europe
por: Culyer, A. J.
Publicado: (1989)

Extracellular Vesicles from Mesenchymal Stem Cells as Novel Treatments for Musculoskeletal Diseases
por: Alcaraz, María José, et al.
Publicado: (2019)

Prevalence of musculoskeletal disorders and rheumatic diseases in the indigenous Qom population of Rosario, Argentina
por: Quintana, Rosana, et al.
Publicado: (2016)

Musculoskeletal and Rheumatic Diseases Induced by Immune Checkpoint Inhibitors: A Review of the Literature
por: Benfaremo, Devis, et al.
Publicado: (2018)

Persistent post-discharge symptoms after COVID-19 in rheumatic and musculoskeletal diseases
por: Leon, Leticia, et al.
Publicado: (2022)

Ixekizumab improves spinal pain, function, fatigue, stiffness, and sleep in radiographic axial Spondyloarthritis: COAST-V/W 52-week results
por: Deodhar, Atul A., et al.
Publicado: (2021)

Can Views and Contact with Nature at Home Help Combat Anxiety and Depression during the Pandemic? Results of the GreenCOVID study
por: Garrido‐Cumbrera, Marco, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ed2304d4bh1qee9f31h2eqkolq